Figure 1From: A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patientsRepresentative result for sequencing and ADx-ARMS. A and E: No.36 patient 19 exon negative by sequencing but positive by ADx-ARMS. C and F: No.34 patient 21 exon negative by sequencing but positive by ADx-ARMS. B: No.13 patient 19 exon 746-751 del D: No.06 patient 21 exon L858R mutationBack to article page